Cecelia H. Boardman, MD, is a board-certified gynecologic oncologist with Virginia Gynecologic Oncology, part of the Sarah Cannon Cancer Network at Henrico Doctors’ Hospital.
Case 2: Monitoring Adverse Reactions With Niraparib Maintenance in Ovarian Cancer
February 4th 2022Cecelia H. Boardman, MD, John K. Chan, MD, and Thomas C. Krivak, MD, share strategies for monitoring adverse events and the optimal duration for niraparib maintenance therapy for a patient with advanced ovarian cancer.
Case 2: Maintenance Strategies for Advanced Ovarian Cancer
February 4th 2022Thomas C. Krivak, MD; John K. Chan, MD; Cecelia H. Boardman, MD; and Ashley Farione, PA-C, review the optimal approach to maintenance therapeutic options for a patient with stage III, high-grade serous epithelial ovarian cancer.
Case 2: Stage III, High-Grade Serous Epithelial Ovarian Cancer
February 4th 2022Experts in gynecologic oncology review the case of a 71-year-old woman who is diagnosed with stage III, high-grade serous epithelial ovarian cancer, and comment on their approach to genetic testing in the frontline setting.